HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells
Although human induced pluripotent stem cells (iPSCs) can serve as a universal cell source for regenerative medicine, the use of iPSCs in clinical applications is limited by prohibitive costs and prolonged generation time. Moreover, allogeneic iPSC transplantation requires preclusion of mismatches b...
Saved in:
Main Authors: | Yoo-Wook Kwon, Hyo-Suk Ahn, Jin-Woo Lee, Han-Mo Yang, Hyun-Jai Cho, Seok Joong Kim, Shin-Hyae Lee, Heung-Mo Yang, Hyun-Duk Jang, Sung Joo Kim, Hyo-Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/8873383 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanosensor-based imaging of realtime dopamine release in neurons derived from iPSCs of patients with Parkinson's disease
by: Nayeon Lee, et al.
Published: (2025-04-01) -
Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs
by: Do-Hun Kim, et al.
Published: (2025-01-01) -
Editorial: Induced pluripotent stem cells (iPSCs) for skeletal muscle diseases
by: Hidetoshi Sakurai, et al.
Published: (2025-01-01) -
Reprogramming of iPSCs to NPCEC-like cells by biomimetic scaffolds for zonular fiber reconstruction
by: Tianhui Chen, et al.
Published: (2025-03-01) -
iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System
by: Andrés Javier Orqueda, et al.
Published: (2016-01-01)